Global Plasma Protein Therapeutics Market Size By Product (Human Serum Protein, Plasma-Derived Clotting Factor), By Application (Research Laboratories And Institutions, Hospitals), By Geographic Scope And Forecast

Plasma Protein Therapeutics Market Size And Forecast

Plasma Protein Therapeutics Market size was valued at USD 25.71 Billion in 2021 and is projected to reach USD 48.06 Billion by 2030, growing at a CAGR of 7.32% from 2023 to 2030.

The rising prevalence of autoimmune disorders, immune deficiency disorders, and bleeding disorders as well as the increasing adoption of plasma protein therapy in neurology and other therapeutic indications are expected to propel the market growth during the forecasted period. The Global Plasma Protein Therapeutics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Plasma Protein Therapeutics Market Definition

Plasma is the straw-colored liquid part of blood. It includes hundreds of proteins that carry out critical functions in the human body, such as antibodies to fight diseases and clotting factors to regulate bleeding. If a person’s body doesn’t have enough of any one plasma protein, it won’t be able to carry out these vital functions, leading to a variety of chronic and life-threatening medical conditions. Plasma therapy or Plasma-derived therapies and their recombinant analogs are collectively called plasma protein therapies. Plasma protein therapy is a therapy that involves the replacement of missing or deficient or missing proteins found in plasma in order to allow their recipients to lead disorder-free and healthier lives.

Deficiency can occur owing to an autoimmune disorder or it can be genetic. There are around 250 products that are derived from plasma. key players generally rely on Immunoglobulin and albumin. owing to advancements in plasma-fractionation techniques, and because of several innovative processes, human blood can be used to produce plasma-derived therapies. That might be used to treat an expanding list of debilitating, life-threatening, and chronic disorders.

Immunoglobulins are used to treat a variety of diseases in individuals with immune deficiencies and autoimmune diseases, clotting-factor therapies are used to treat individuals with hemophilia A and B and other bleeding disorders, and albumin is used to treat individuals with shock, trauma, burns, and other conditions in acute settings. Plasma proteins are commonly used in replacement therapies to address disorders like coagulation factor deficiency in the field of hemostasis. This deficiency might be genetic or the result of an immune disorder. The deficiency can emerge as a side effect of cancer treatment. Fibrinogen is used as replacement therapy for the treatment of hemorrhagic diathesis in diseases, such as dysfibrinogenemia, afibrinogenemia, and hypofibrinogenemia.

Global Plasma Protein Therapeutics Market Overview

The rising prevalence of autoimmune disorders, immune deficiency disorders, and bleeding disorders as well as the increasing adoption of plasma therapy in neurology and other therapeutic indications are expected to propel the market growth during the forecasted period. There is a rise in the geriatric population, who are more prone to neurological disorders. Additionally, increasing investments in research and development programs by pharmaceutical and biotechnology companies fuels market growth. The ongoing research and development in the plasma protein therapy segment are expected to drive its adoption through several applications. The growing adoption of therapeutic protein drugs in the treatment of a broad range of clinical symptoms is expected to create potential for this market in future years.

The approval of some new plasma-derived therapies throughout the world will help to increase demand. Over the forecasted period, the aforementioned reasons are likely to boost the growth of the Plasma Protein Therapeutics Market. In addition, approval of plasma products across multiple indications, increasing R & D activities, and high demand for advanced therapeutic options are expected to fuel the market growth. Technological advancements, favorable reimbursement policies, and improved standard of living have led to increased life expectancy, contributing to a rise in the geriatric population.

Additionally, plasma-derived IG is used to treat a wide range of autoimmune and inflammatory diseases However, the rising use of high-dose therapy, particularly in autoimmune neurologic disorders, is the main cause for IG demand’s continued strong growth. Moreover, plasma protein therapies are used in the treatment of rare diseases. Immunoglobulins are used to treat various diseases in individuals with immune deficiencies and autoimmune diseases, clotting-factor therapies are used to treat individuals with hemophilia A and B and other bleeding disorders, and albumin is used to treat people with shock, trauma, burns, and other conditions in acute settings. As a result, plasma protein therapeutics and their applications are driven by these factors.

However, the major restrain for the market is imposed stringent restrictions and regulations regarding plasma therapy, particularly for the handling of plasma protein products. There is a lack of reimbursement policies, therefore, might affect the adoption of plasma therapy. Also, the required lead time between plasma collection and getting the product is long, it possesses challenges in front of the market. Furthermore, Increased awareness and treatment of immune deficiencies in developing countries have increased the global demand for immunoglobulin. This is a lucrative growth opportunity for market growth.

Global Plasma Protein Therapeutics MarketSegmentation Analysis

The Global Plasma Protein Therapeutics Market is Segmented on the basis of Product, Application, and Geography.

Plasma Protein Therapeutics Market, By Product

• Human Serum Protein
• Plasma-Derived Clotting Factor
• Immunoglobulin
• High Immunoglobulin

Based on Product, The market is segmented into Human Serum Protein, Plasma-Derived Clotting Factor, Immunoglobulin, and High Immunoglobulin. The Immunoglobulin segment held the major market share and is projected to grow at a significant CAGR during the forecasted period. This is owing to the rising use of immunoglobulin for primary as well as secondary immunodeficiency disorders in order to cure bacterial and viral infections.

Plasma Protein Therapeutics Market, By Application

• Research Laboratories And Institutions
• Hospitals
• Stand-Alone Blood Banks

Based on Application, The market is segmented into Research Laboratories And Institutions, Hospitals, and Stand-Alone Blood Banks. The Hospitals segment is expected to have a significant CAGR and is anticipated to hold a major market share in the forecast period. This is owing to the increasing adoption of plasma therapy in the hospital segment for the treatment of various disorders.

Plasma Protein Therapeutics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, The Global Plasma Protein Therapeutics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America will hold a significant share of the market, followed by Europe. The market is expected to be driven by factors such as the growing geriatric population, the presence of a large patient base, and well-developed infrastructure for storing and maintaining high-quality source plasma across the respective region.

Key Players

The “Global Plasma Protein Therapeutics Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Baxter, CSL Behring, Grifols Therapeutics, Octapharma, Abeona Therapeutics, ADMA Biologics, Amag Pharmaceuticals, Antares Pharma, BioDelivery Sciences, Bio Products Laboratory, Biota Pharmaceuticals, Biotest Pharmaceuticals, and China Biologic Products.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.